Study Stopped
The patient completed the follow-up (FU), and the study was concluded.
The Efficacy and Safety of Shoulder Chuna on in Patients With Shoulder Pain Caused by Traffic Accidents
Shoulder chuna
2 other identifiers
interventional
98
1 country
1
Brief Summary
This study is a double blind, randomized controlled trail. condition/disease: Patient with acute shoulder pain and restricted movement due to a traffic accident. treatment/intervention: Chuna therapy for the shoulder, including integrated Korean medicine treatment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2024
CompletedFirst Posted
Study publicly available on registry
October 3, 2024
CompletedStudy Start
First participant enrolled
November 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 5, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 10, 2025
CompletedMarch 27, 2026
March 1, 2026
8 months
September 26, 2024
March 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Numeric Rating Scale(NRS) of Shoulder pain
NRS is a pain scale in which the patient indicates their subjective pain as a whole number from 0 to 10. The participant is asked to report their shoulder pain and discomfort using NRS, where 0 indicates \'no pain or discomfort\' and 10 indicates \'the most severe pain and discomfort imaginable\'.
Screening, From baseline(Day2) up to Discharge 1 day, 2week after enrollment, 1month after enrollment, 3month after enrollment
Secondary Outcomes (6)
Location of shoulder joint displacement
Screening, From baseline(Day2) up to Discharge 1 day, 2week after enrollment, 1month after enrollment, 3month after enrollment
Shoulder Pain intensity scale: Visual Analogue Scale (VAS)
From baseline(Day2) up to Discharge 1 day
Physical examination (Shoulder active range of motion)
From baseline(Day2) up to Discharge 1 day
Shoulder Pain and Disability Index(SPADI)
From baseline(Day2) up to Discharge 1 day, 2week after enrollment, 1month after enrollment, 3month after enrollment
EuroQol 5-Dimension (EQ-5D)
From baseline(Day2) up to Discharge 1 day, 2week after enrollment, 1month after enrollment, 3month after enrollment
- +1 more secondary outcomes
Study Arms (2)
Shoulder chuna treatment
EXPERIMENTALDuring the hospitalization period, Chuna therapy for the shoulder joint will be performed once a day for a total of 10 to 15 minutes, including before, during, and after the treatment. The practitioner will assess the condition and select one of three techniques-posterior displacement, anterior displacement, or lateral displacement-to apply Chuna therapy
Korean medical treatment
ACTIVE COMPARATORThe control group were received Korean medical treatment everyday after hospitalization: acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.
Interventions
The Shoulder Chuna therapy for the shoulder joint will be performed on the affected shoulder from the second day of hospitalization until the day before discharge.
acupuncture treatment, chuna, pharmacoacupuncture, Korean herbal medicine
Eligibility Criteria
You may qualify if:
- Patients aged 19-69 years on the date they sign the consent form.
- Patients with shoulder pain and restricted movement occurring within 5 days after a traffic accident.
- Patients who are hospitalized due to traffic accident.
- Patients with NRS of shoulder pain ≥ 5 with restricted movement due to a traffic accident.
- Patients who provide consent to participate in the trial and return the informed consent form.
You may not qualify if:
- Patients with a specific serious disease that may cause shoulder pain: malignancy, spondylitis, inflammatory spondylitis, etc.
- Patients with progressive neurological deficits or with severe neurological symptoms.
- Patients with medical history of cervical surgery or shoulder surgery within the last three weeks.
- Patients with a specific serious disease that may interfere with the interpretation of the therapeutic effects or results: malignancy, spondylitis, inflammatory spondylitis, etc.
- Chuna therapy is deemed inappropriate or unsafe due to conditions like fractures, dislocations, ligament tears, or unstable healing fractures; skeletal demineralization and ligament laxity with subluxation or dislocation; or inflammation
- Presence of other chronic diseases that could interfere with treatment outcomes or interpretation, such as cardiovascular disease, kidney disease, diabetic neuropathy, dementia, or epilepsy
- Currently taking steroids, immunosuppressants, psychiatric medications, or other drugs that may affect study results
- Acupuncture is deemed inappropriate or unsafe, such as in patients with bleeding disorders, those on anticoagulant therapy, those with severe diabetes prone to infection, or those with severe cardiovascular disease
- Patients who are pregnant or planning to become pregnant.
- Patients who are presence of severe mental illness
- Patients who are participated in clinical trials other than observational studies without therapeutic intervention.
- Patients who are difficult to complete the research participation agreement.
- Other patients whose participation in the trial is judged by a researcher to be problematic.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jaseng Hospital of Korean Medicine
Seoul, Gangnam-Gu, 135-896, South Korea
Study Officials
- STUDY DIRECTOR
In-Hyuk Ha, phD
Jaseng Medical Foundation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 26, 2024
First Posted
October 3, 2024
Study Start
November 4, 2024
Primary Completion
July 5, 2025
Study Completion
November 10, 2025
Last Updated
March 27, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share